152 related articles for article (PubMed ID: 4514633)
21. Immune factors in human cancer: malignant melanomas, skeletal and soft tissue sarcomas.
Morton DL; Eilber FR; Malmgren RA
Prog Exp Tumor Res; 1971; 14():25-42. PubMed ID: 5002728
[No Abstract] [Full Text] [Related]
22. Further definition by cytotoxicity tests of cell surface antigens of human sarcomas in culture.
Bloom ET
Cancer Res; 1972 May; 32(5):960-7. PubMed ID: 4502173
[No Abstract] [Full Text] [Related]
23. Unblocking or activation of the cellular immune mechanism by induced proteolysis in patients with cancer.
Thornes RD
Lancet; 1974 Aug; 2(7877):382-4. PubMed ID: 4137344
[No Abstract] [Full Text] [Related]
24. Delayed cutaneous hypersensitivity reactions to melanoma antigen.
Holmes EC; Roth JA; Morton DL
Surgery; 1975 Aug; 78(2):160-4. PubMed ID: 1154259
[TBL] [Abstract][Full Text] [Related]
25. [Problems of tumor immunity and the possibility of immunotherapy in tumor].
Shimoyama M
Nihon Rinsho; 1971; 29(6):1515-29. PubMed ID: 4933610
[No Abstract] [Full Text] [Related]
26. Effect of radiation therapy on mumps-delayed type hypersensitivity reaction in lymphoma and carcinoma patients.
Check JH; Damsker JI; Brady LW; O'Neill EA
Cancer; 1973 Sep; 32(3):580-4. PubMed ID: 4726964
[No Abstract] [Full Text] [Related]
27. In vitro study of cellular immunity against autochthonous human cancer.
Segall A; Weiler O; Genin J; Lacour J; Lacour F
Int J Cancer; 1972 Mar; 9(2):417-25. PubMed ID: 4339416
[No Abstract] [Full Text] [Related]
28. Tumor-specific cellular immunity.
Cohen AM; Burdick JF; Ketcham AS
J Surg Res; 1971 Aug; 11(8):421-31. PubMed ID: 4936302
[No Abstract] [Full Text] [Related]
29. Human tumor immunology.
Oettgen HF; Old LJ; Boyse EA
Med Clin North Am; 1971 May; 55(3):761-85. PubMed ID: 4995918
[No Abstract] [Full Text] [Related]
30. Lymphocyte blastogenic responses to cultured allogeneic tumor cells in vitro.
Anderson RJ; McBride CM; Hersh EM
Cancer Res; 1972 May; 32(5):988-92. PubMed ID: 4336032
[No Abstract] [Full Text] [Related]
31. Evidence for immune reactivity against neoplasms.
McKhann CF; Jagarlamoody SM
Transplant Rev; 1971; 7():55-77. PubMed ID: 4112673
[No Abstract] [Full Text] [Related]
32. Detection of tumor-associated antigen in human melanoma cell line supernatants.
Grimm EA; Silver HK; Roth JA; Chee DO; Gupta RK; Morton DL
Int J Cancer; 1976 May; 17(5):559-64. PubMed ID: 1270174
[TBL] [Abstract][Full Text] [Related]
33. Blastogenic response of normal lymphocytes to cultured lymphoid cells and non-lymphoid neoplastic cells.
Han T
Immunology; 1972 Sep; 23(3):355-9. PubMed ID: 4529836
[TBL] [Abstract][Full Text] [Related]
34. Studies on specificity of cell-mediated immunity to human tumors.
Takasugi M; Mickey MR; Terasaki PI
J Natl Cancer Inst; 1974 Dec; 53(6):1527-38. PubMed ID: 4140237
[No Abstract] [Full Text] [Related]
35. Immunologic effects of BCG in patients with malignant melanoma: specific evidence for stimulation of the 'secondary' immune response.
Chess L; Bock GN; Ungaro PC; Buchholz DH; Mardiney MR
J Natl Cancer Inst; 1973 Jul; 51(1):57-65. PubMed ID: 4720886
[No Abstract] [Full Text] [Related]
36. Immunologic testing as a guide to cancer management.
Wanebo HJ
Surg Clin North Am; 1979 Apr; 59(2):323-47. PubMed ID: 375447
[No Abstract] [Full Text] [Related]
37. Immunocompetence testing in patients with one of the four common operable cancers--a review.
Wanebo HJ; Pinsky CM; Beattie EJ; Oettgen HF
Clin Bull; 1978; 8(1):15-22. PubMed ID: 668106
[No Abstract] [Full Text] [Related]
38. Delayed-type hypersensitivity response is a predictor of peripheral blood T-cell immunity after HER-2/neu peptide immunization.
Disis ML; Schiffman K; Gooley TA; McNeel DG; Rinn K; Knutson KL
Clin Cancer Res; 2000 Apr; 6(4):1347-50. PubMed ID: 10778962
[TBL] [Abstract][Full Text] [Related]
39. Newer concepts of cancer of the colon and rectum: delayed hypersensitivity responses of patients with carcinoma of the colon and other solid tumors.
Kronman BS; Shapiro HM; Localio SA
Dis Colon Rectum; 1972; 15(2):106-10. PubMed ID: 5026786
[No Abstract] [Full Text] [Related]
40. Specific antigen stimulated lymphocyte proliferation in osteosarcoma.
Gainor BJ; Forbes JT; Enneking WF; Smith RT
Cancer; 1976 Feb; 37(2):743-50. PubMed ID: 1062227
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
